Veru Inc.

VERU ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
Revenue $22.1M $32.6M $24.5M $31.5M $35.0M $18.6K $22.2M $27.5M
Cost of Revenue $8.8M $13.6M $11.4M $14.0M $14.4M $8.7M $9.3M $14.0M
Gross Profit $13.3M $19.0M $13.1M $17.5M $20.6M $9.9M $12.9M $13.5M
Gross Margin 60.3% 58.2% 53.6% 55.6% 58.9% 53,138.6% 58.2% 49.1%
Operating Expenses
Research & Development $99.4K $219.8K $5.6K $4.7K $5.3K $10.9K $381 $105.9K
SG&A Expense $8.7M $12.1M $9.1M $7.5M $9.6M $6.5M $6.6M $7.0M
Operating Income $3.0M $6.6M $3.9M $9.8M $10.9M $3.3M $4.3M $4.7M
Operating Margin 13.6% 20.3% 16.0% 31.1% 31.2% 17,750.3% 19.6% 17.1%
Interest Expense — — — — — — — —
Pretax Income $2.8M $6.7M $4.0M $9.9M $10.8M $3.2M $4.2M —
Income Tax Expense $2.5M $2.3M $1.5M $-4.4M $-4.5M $-2.2M $-2.5M $-1.5M
Net Income $344.7K $4.3M $2.4M $14.3M $15.3M $5.4M $6.7M $6.5M
Net Margin 1.6% 13.3% 9.9% 45.6% 43.7% 29,081.9% 30.3% 23.7%
EPS (Basic) $0.01 $0.15 $0.09 $0.51 $0.55 $0.20 $0.25 $0.25
EPS (Diluted) $0.01 $0.15 $0.08 $0.50 $0.53 $0.19 $0.24 $0.24
Shares Outstanding (Basic) 28.7M 28.5M 28.5M 28.4M 27.7M 27.3M 27.0M 25.7M
Shares Outstanding (Diluted) 28.9M 28.9M 28.9M 28.7M 28.9M 29.0M 28.5M 27.8M
Dividends Per Share — — $0.21 $0.26 $0.22 $0.20 — —
← Newer Page 2 of 2 Older →